Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid Tumors
Stopped the company is liquidated
Conditions
- Advanced or Recurrent Solid Tumors
- Breast Neoplasm
Interventions
- BIOLOGICAL: Injections Subcutaneously Talazoparib
- DRUG: Oral capsules Talazoparib
Sponsor
Center Trials & Treatment
Collaborators